Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Human hair is made up of different keratins, some strong and some weak, with specific types appearing at various stages of hair growth.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Sebocytes play a key role in controlling androgen levels in human skin.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Young patients are more likely to develop autoimmune diseases, while elderly patients are more prone to organ failure after DRESS.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Only a few hair-specific keratins are linked to inherited hair disorders.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Finasteride improves hair loss in women with hyperandrogenism.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Asiasari radix extract promotes hair growth and increases protein synthesis and cell proliferation.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.